About Phil Reaston
Form D filings for Emerge Diagnostics from 2014 to 2021 list Phil Reaston as executive officer.
Phil Reaston first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Phil Reaston in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Phil Reaston works with at each company, as listed on that company's latest Form D.
Emerge Diagnostics, Inc. · Form D, Mar 3, 2021
TW
Thomas Webster
Director
MS
Mark Sampson
Director
GW
Greer Woodruff
Director
MC
Michael Connor
Director
RT
Robert Thompson
Director
ML
Murray Lappe
Director
MD
MaryRose Cusimano-Reaston, Ph.D.
President and CEO